These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy. Pehling G; Tessari P; Gerich JE; Haymond MW; Service FJ; Rizza RA J Clin Invest; 1984 Sep; 74(3):985-91. PubMed ID: 6381541 [TBL] [Abstract][Full Text] [Related]
4. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function. Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069 [TBL] [Abstract][Full Text] [Related]
8. Reversal of insulin resistance in type I diabetes after treatment with continuous subcutaneous insulin infusion. Lager I; Lönnroth P; von Schenck H; Smith U Br Med J (Clin Res Ed); 1983 Dec; 287(6406):1661-4. PubMed ID: 6416540 [TBL] [Abstract][Full Text] [Related]
10. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans. Saccà L; Sherwin R; Hendler R; Felig P J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832 [TBL] [Abstract][Full Text] [Related]
11. Insulin kinetics in type I diabetic patients treated by continuous intraperitoneal insulin infusion: influence of anti-insulin antibodies. Lassmann-Vague V; Belicar P; Alessis C; Raccah D; Vialettes B; Vague P Diabet Med; 1996 Dec; 13(12):1051-5. PubMed ID: 8973887 [TBL] [Abstract][Full Text] [Related]
12. Circadian variation of basal and postprandial insulin sensitivity in healthy individuals and patients with type-1 diabetes. Tatò F; Tatò S; Beyer J; Schrezenmeir J Diabetes Res; 1991 May; 17(1):13-24. PubMed ID: 1816976 [TBL] [Abstract][Full Text] [Related]
13. Intraperitoneal delivery of insulin by a portable microinfusion pump. Eaton RP; Friedman NM; Spencerr WJ Metabolism; 1980 Aug; 29(8):699-702. PubMed ID: 6995791 [TBL] [Abstract][Full Text] [Related]
14. Postprandial exercise in type I diabetic patients on multiple daily insulin injection regimen. Trovati M; Anfossi G; Vitali S; Mularoni E; Massucco P; De Facis R; Carta Q; Lucchina PG; Emanuelli G Diabetes Care; 1988 Feb; 11(2):107-10. PubMed ID: 3289860 [TBL] [Abstract][Full Text] [Related]
15. Immunoreactive gastric inhibitory polypeptide response to a meal during the first eighteen months after diagnosis of type 1 (insulin dependent) diabetes mellitus. Krarup T; Madsbad S; Moody AJ J Clin Endocrinol Metab; 1985 Jan; 60(1):120-5. PubMed ID: 3880559 [TBL] [Abstract][Full Text] [Related]
16. Continuous subcutaneous insulin infusion: comparison of plasma insulin profiles after infusion or bolus injection of the mealtime dose. Home PD; Pickup JC; Keen H; Alberti KG; Parsons JA; Binder C Metabolism; 1981 May; 30(5):439-42. PubMed ID: 6112654 [TBL] [Abstract][Full Text] [Related]
17. Insulin-mediated glucose disposal in type 1 (insulin-dependent) diabetic subjects treated by continuous subcutaneous or intraperitoneal insulin fusion. Beylot M; Khalfallah Y; Laville M; Sautot G; Dechaud H; Serusclat P; Berthezene F; Riou JP; Mornex R Diabete Metab; 1987; 13(4):450-6. PubMed ID: 3315766 [TBL] [Abstract][Full Text] [Related]